Treatment of lung cancer
288 results
1 - 100
Treatment of lung cancer 
Elemene for the treatment of lung cancer: Cochrane systematic review- Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non‐small cell lung cancer
- First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
- Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
- Anti‐TIGIT inhibitors plus PD‐1 or PD‐L1 inhibitors versus PD‐1 or PD‐L1 inhibitors for first‐line treatment of advanced non‐small cell lung cancer
- Immune checkpoint inhibitors plus platinum‐based chemotherapy compared to platinum‐based chemotherapy with or without bevacizumab for first‐line treatment of older people with advanced non‐small cell lung cancer
- Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation
- Lung cancers
- Interventions for smoking cessation in people diagnosed with lung cancer
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
- Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
- Drugs for preventing lung cancer in healthy people
- Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission: Cochrane systematic review
- Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): Cochrane systematic review
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Exercise training for advanced lung cancer
- Surgery for local and locally advanced non‐small cell lung cancer
- Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
- Chemotherapy for non‐small cell lung cancer
- Surgery versus radiosurgery for patients with a solitary brain metastasis from non‐small cell lung cancer
Spiral CT detects early lung cancer, but screening use is premature- Screening for lung cancer
- Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
- Surgery for limited‐stage small‐cell lung cancer
- Chemotherapy for brain metastases from small cell lung cancer: Cochrane systematic review
- Second‐line chemotherapy for non‐small cell lung cancer
- Problems of childhood or adolescence cancer survivors in adulthood
- Non‐invasive interventions for improving well‐being and quality of life in patients with lung cancer
- Postoperative radiotherapy for non‐small cell lung cancer
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- Therapeutic vaccines for advanced non‐small cell lung cancer
- Population screening for cancer
- Biosimilar monoclonal antibodies for cancer treatment in adults
- Palliative radiotherapy regimens for patients with thoracic symptoms from non‐small cell lung cancer
- Early versus late chest radiotherapy in patients with limited‐stage small cell lung cancer
- PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer
- Palliative endobronchial brachytherapy for non‐small cell lung cancer
- Platinum-based chemotherapy regimens for small-cell lung cancer
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
- Prophylactic cranial irradiation for extensive‐stage small cell lung cancer
- Pre-operative chemotherapy in non-small cell lung cancer
- Systematic review: lung cancer screening with CT decreases mortality but with significant harms
- Telehealth is effective for providing palliative care to adults with advanced lung cancer
- Oncological emergencies
- Asbestos-related diseases
- Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
- Bone tumours
- Chemotherapy for advanced non-small cell lung cancer
- Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer: Cochrane systematic review
- Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer: Cochrane systematic review
- Interventions for cough in cancer
- Chemotherapy versus best supportive care for extensive small cell lung cancer
- Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: Cochrane systematic review
- Stereotactic body radiation therapy versus more fractionated radical radiotherapy for adults with stage I/II non‐small cell lung cancer: a systematic review and network meta‐analysis
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
- Post-operative radiotherapy for ductal carcinoma in situ of the breast: Cochrane systematic review
- Chemotherapy and surgery versus surgery alone in non‐small cell lung cancer
- Concurrent chemoradiotherapy in non-small cell lung cancer
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
- Brain and spinal cord tumours
- Exercise training undertaken by people within 12 months of lung resection for non‐small cell lung cancer